The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSegro Share News (SGRO)

Share Price Information for Segro (SGRO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 899.00
Bid: 898.60
Ask: 899.00
Change: 2.60 (0.29%)
Spread: 0.40 (0.045%)
Open: 887.60
High: 901.80
Low: 887.40
Prev. Close: 896.40
SGRO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Retailers suffer as UK earnings lag inflation

Tue, 19th Jul 2022 08:39

(Alliance News) - Furniture seller Made.com on Tuesday lowered guidance as UK consumers rein in spending and warned that it may need to raise additional financing.

The warning from the retailer came as official figures showed UK earnings rising at only half the rate of inflation.

Made.com said gross sales in the first half of 2022 were down 19% year-on-year, though up 55% from pre-virus levels.

"Recent trading has been volatile, and the worsening of consumer confidence has impacted demand for discretionary big-ticket items, making new customer acquisition at financially attractive rates challenging," Made.com cautioned.

Profit for 2022 will take a GBP20 million one-off hit from clearance work related to excess inventory and additional costs in its supply chain.

For 2022, Made now expects gross sales to fall by between 15% to 30%. It had previously expected an outcome ranging from flat sales to a 15% fall.

Revenue guidance has been lowered to a range of a 9% fall to a 24% fall from between 8% growth and a 7% decline previously.

Made said it is considering options to strength its balance sheet, as it lowered its 2022 year-end cash forecast to between GBP5 million and GBP30 million from between GBP40 million and GBP65 million previously.

Made.com shares were down 37% early Tuesday at 24.15p.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.6% at 7,183.32

----------

Hang Seng: down 0.8% at 20,680.43

Nikkei 225: closed up 0.7% at 26,961.68

S&P/ASX 200: closed down 0.6% at 6,649.60

----------

DJIA: closed down 215.65 points, or 0.7%, at 31,072.61

S&P 500: closed down 32.31 points, or 0.8%, at 3,830.85

Nasdaq Composite: closed down 92.37 points, or 0.8%, at 11,360.05

----------

EUR: flat at USD1.0164 (USD1.0167)

GBP: soft at USD1.1970 (USD1.1994)

USD: lower at JPY137.74 (JPY138.17)

GOLD: lower at USD1,708.91 per ounce (USD1,709.33)

OIL (Brent): higher at USD106.29 a barrel (USD105.55)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Tuesday's key economic events still to come

1000 CEST EU ECB bank lending survey

1100 CEST EU harmonised consumer price index

1100 CEST EU construction output

0830 EDT US new residential construction

1630 EDT US API weekly statistical bulletin

0855 EDT US Johnson Redbook retail sales index

----------

The UK unemployment rate remained unchanged in the three months to May, in line with market expectations. The jobless rate was 3.8%, the same level as in the three months in April, according to the Office for National Statistics. A year earlier, the unemployment rate had sat at 4.9%. The latest figure was in line with FXStreet cited consensus.

----------

UK wage growth figures, meanwhile, showed average earnings including bonuses rose 6.2% on an annual basis, slowing from 6.8% in the reading for April and below FXStreet-cited consensus of 6.9%. Excluding bonuses, wages grew 4.3%, in line with consensus and picking up from 4.2% growth in April. That means UK earnings by both measures continue to lag consumer price inflation, which ran at 9.1% in May.

----------

BROKER RATING CHANGES

----------

Barclays starts Haleon with 'equal weight' - price target 348 pence

----------

Oddo BHF starts Vodafone with 'neutral' - price target 140 pence

----------

JPMorgan places Segro on 'positive catalyst watch'

----------

COMPANIES - FTSE 100

----------

Business publisher and events organiser Informa backed annual expectations. Informa still expects revenue between GBP2.15 billion to GBP2.25 billion for 2022, with adjusted operating profit between GBP470 million to GBP490 million. At best, this would represent revenue growth of 25% from GBP1.80 billion in 2021 and adjusted operating profit growth of 26% from GBP388.4 million. Guidance does not include any contribution from Industry Dive, which Informa announced it has acquired for up to USD525 million. The initial cash consideration is USD389 million. "Industry Dive brings a scalable, single proprietary technology platform, which will enable us to expand our digital services capabilities and deliver content led services to our B2B audiences," Informa said. Informa said that for the first half of 2022, it expects to report underlying revenue growth of 40%, helped by a return of live events.

----------

COMPANIES - FTSE 250

----------

Cybersecurity company Darktrace said it expects revenue growth of 48% in the financial fourth quarter that ended June 30. It forecasts an annualised recurring revenue climb of 42%. "Darktrace continued to deliver strong sales performance in its fourth quarter, adding over 500 net new customers, and bringing the group's customer base at year-end to over 7,400. This reflects year-over-year growth of approximately 32%," the company said. For the year, Darktrace expects revenue of USD417.0 million, up 48%. Its adjusted earnings before interest, tax, depreciation and amortisation margin is tipped to land at 19.5%, above its previous guidance range of 15% to 17%. For the new financial year, revenue growth will slow. Darktrace expects a revenue rise of between 29% and 32%. Growth has been hit by foreign currency movements. "It cautions that particularly for the first six-to-nine months of the year, year-over-year growth comparisons are expected to be dampened by the impact that significant movements in exchange rates relative to the prior year period have already had, and are expected to continue to have, on the conversion of British pound and euro-denominated ARR to US dollar-denominated revenue," Darktrace explained.

----------

COMPANIES - SMALL CAP

----------

Wise has kicked off its new financial year with growth in revenue and volumes. In the three months ended June, the international money transfer service provider said revenue grew 51% yearly to GBP185.9 million from GBP123.5 million. Quarter-on-quarter, revenue was up 21%. Transaction volumes were 49% higher yearly and 14% higher quarterly at GBP24.4 billion. "Volume growth was driven by a higher number of active customers that are increasingly using the Wise Account and Wise Business products, which in turn also leads to a higher average volume per customer. The growth also reflects to a lesser extent, more variable drivers which include people and businesses responding to increased levels of FX volatility and the translation impact from FX movements which was a tailwind in the quarter, compared with a headwind in FY22. On a constant currency basis volume grew 45% year-on-year," Wise explained. Wise left revenue guidance unchanged. It still expects annual growth of between 30% and 35% for financial 2023.

----------

COMPANIES - GLOBAL

----------

Novartis reported a drop in second-quarter income and a fall in sales but nonetheless reconfirmed its guidance for 2022 as a whole. The Basel, Switzerland-based pharmaceutical company posted net income of USD1.70 billion in the second quarter of 2022, representing a 36% drop against the previous year's figure of USD2.65 billion. Earnings per share fell by a similar percentage, dropping 36% to USD0.77 per share from USD1.19 the previous year. Net sales declined more modestly, slipping 1.4% to USD12.78 billion from USD12.96 billion. The firm explained that price erosion and competition from generic drugs was the reason behind the drop in sales. In contrast, key sales drivers were arthritis and psoriasis drug Cosentyx, heart failure treatment Entresto, spinal muscular atrophy drug Zolgensma, breast cancer drug Kisqali, multiple sclerosis therapy Kesimpta, and cholesterol drug Leqvio - all of which grew in double digits, Novartis added.

----------

Tuesday's shareholder meetings

Biotech Growth Trust PLC - AGM

Clean Power Hydrogen PLC - AGM

e-Therapeutics PLC - AGM

Norcros PLC - AGM

Ten Lifestyle Group PLC - GE re commitment to sustainability, B Corp certification

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Feb 2023 15:47

UK earnings, trading statements calendar - next 7 days

Monday 13 February 
no events scheduled 
Tuesday 14 February 
Carr's Group PLCFull Year Results
Coca-Cola HBC AGFull Year Results
Plus500 LtdFull Year Results
Tui AGQ1 Results
UP Global Sourcing Holdings PLCTrading Statement
Wednesday 15 February 
Barclays PLCFull Year Results
Brunner Investment Trust PLCFull Year Results
Dunelm Group PLCHalf Year Results
Equipmake Holdings PLCHalf Year Results
Gattaca PLCTrading Statement
Glencore PLCFull Year Results
Hargreaves Lansdown PLCHalf Year Results
Pan African Resources PLCHalf Year Results
Thursday 16 February 
Centrica PLCFull Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Indivior PLCFull Year Results
MJ Gleeson PLCHalf Year Results
Moneysupermarket.com Group PLCFull Year Results
Relx PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
South32 LtdHalf Year Results
Standard Chartered PLCFull Year Results
Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 09:47

LONDON BROKER RATINGS: Bank of America and Oddo BHF cut Whitbread

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 07:54

LONDON BRIEFING: UK inflation cools slightly to 10.5% in December

(Alliance News) - Stocks in London are set to open lower on Wednesday, following news that UK inflation cooled slightly more than expected in December and the Bank of Japan kept its loose monetary policy unchanged.

Read more
10 Jan 2023 10:11

LONDON BROKER RATINGS: Jefferies likes Inchcape; HSBC cuts Clarkson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
9 Jan 2023 09:49

LONDON BROKER RATINGS: Peel Hunt raises real estate; UBS cuts Ashmore

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
20 Dec 2022 09:09

LONDON MARKET OPEN: Gloom descends on global markets

(Alliance News) - European markets opened in the red on Tuesday, after a weak performance from Asian equities, after the Bank of Japan tightened monetary policy slightly.

Read more
15 Dec 2022 09:25

LONDON BROKER RATINGS: Goldman Sachs likes Big Yellow, Great Portland

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
9 Dec 2022 10:02

LONDON BROKER RATINGS: JPMorgan cuts Assura; BofA cuts Synthomer

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
30 Nov 2022 09:48

Segro says 19-year senior unsecured bond issue is oversubscribed

(Alliance News) - Segro PLC on Wednesday said it has priced a 19-year senior unsecured bond issue under its medium-term note programme, which was oversubscribed.

Read more
24 Nov 2022 09:55

LONDON BROKER RATINGS: Numis cuts discoverIE; UBS likes Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday afternoon:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Nov 2022 07:51

LONDON BRIEFING: AB Foods share buyback; Persimmon sales rate weakens

(Alliance News) - Stocks in London are seen opening lower on Tuesday, as a cautious start to the week continues, with focus shifting to US politics.

Read more
4 Nov 2022 10:15

LONDON BROKER RATINGS: Liberum cuts British Land; Exane cuts Sainsbury

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

Read more
1 Nov 2022 10:09

LONDON BROKER RATINGS: UBS raises Auto Trader; Berenberg likes Next 15

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.